IQVIA Holdings Inc
IQV187.490USD
+6.530+3.61%
종가 02/06, 16:00（ET）시세는 15분 지연됩니다
31.80B시가총액
23.70P/E TTM
자세한 내용은 IQVIA Holdings Inc 회사
IQVIA Holdings Inc. is a global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. Its segments include Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides mission-critical information, technology solutions and real-world insights and services to the Company’s life science clients. The Research & Development Solutions segment primarily serves biopharmaceutical customers, and provides outsourced clinical research and clinical trial-related services. The Contract Sales & Medical Solutions segment provides healthcare provider (including contract sales) and patient engagement services to both biopharmaceutical customers and the broader healthcare market. It offers a set of strategic and implementation consulting services, including advanced analytics and commercial processes outsourcing services.
IQVIA Holdings Inc 정보
종목 코드 IQV
회사 이름IQVIA Holdings Inc
상장일May 09, 2013
CEOBousbib (Ari)
직원 수88000
유형Ordinary Share
회계 연도 종료May 09
주소2400 Ellis Road
도시DURHAM
증권 거래소NASDAQ OMX NASDAQ Basic NYSE
국가United States of America
우편 번호27703
전화19199982000
웹사이트https://ir.iqvia.com/
종목 코드 IQV
상장일May 09, 2013
CEOBousbib (Ari)
IQVIA Holdings Inc의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Mr. Ari Bousbib
Mr. Ari Bousbib
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.35M
--
Mr. Ronald E. (Ron) Bruehlman
Mr. Ronald E. (Ron) Bruehlman
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
46.46K
-907.00%
Mr. John G. Danhakl
Mr. John G. Danhakl
Independent Director
Independent Director
30.85K
-117138.00%
Mr. Eric M. Sherbet
Mr. Eric M. Sherbet
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
21.11K
--
Ms. Colleen A. Goggins
Ms. Colleen A. Goggins
Independent Director
Independent Director
16.83K
+1592.00%
Dr. John M. Leonard, M.D.
Dr. John M. Leonard, M.D.
Lead Independent Director
Lead Independent Director
15.38K
+1592.00%
Ms. Carol J. Burt
Ms. Carol J. Burt
Independent Director
Independent Director
7.01K
+1047.00%
Mr. James A. Fasano
Mr. James A. Fasano
Independent Director
Independent Director
2.74K
+1676.00%
Mr. John P. Connaughton
Mr. John P. Connaughton
Independent Director
Independent Director
1.05K
+1047.00%
Mr. Bhavik Patel
Mr. Bhavik Patel
President, Commercial Solutions
President, Commercial Solutions
863.00
-84.00%
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Ari Bousbib
Mr. Ari Bousbib
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.35M
--
Mr. Ronald E. (Ron) Bruehlman
Mr. Ronald E. (Ron) Bruehlman
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
46.46K
-907.00%
Mr. John G. Danhakl
Mr. John G. Danhakl
Independent Director
Independent Director
30.85K
-117138.00%
Mr. Eric M. Sherbet
Mr. Eric M. Sherbet
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
21.11K
--
Ms. Colleen A. Goggins
Ms. Colleen A. Goggins
Independent Director
Independent Director
16.83K
+1592.00%
Dr. John M. Leonard, M.D.
Dr. John M. Leonard, M.D.
Lead Independent Director
Lead Independent Director
15.38K
+1592.00%
수익 분석
통화: USD마지막 업데이트: Tue, Jan 6
통화: USD마지막 업데이트: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
기업이 아직 관련 데이터를 공개하지 않았습니다.
지역별USD
이름
수익
비율
Americas
1.93B
47.15%
Europe & Africa Region
1.30B
31.63%
Asia Pacific Region
870.00M
21.22%
사업별
지역별
기업이 아직 관련 데이터를 공개하지 않았습니다.
주식 보유 통계
마지막 업데이트: Sat, Jan 10
마지막 업데이트: Sat, Jan 10
주주
주주 유형
주주
주주
비율
The Vanguard Group, Inc.
11.54%
Harris Associates L.P.
6.71%
BlackRock Institutional Trust Company, N.A.
5.57%
State Street Investment Management (US)
4.45%
GIC Private Limited
3.86%
기타
67.87%
주주
주주
비율
The Vanguard Group, Inc.
11.54%
Harris Associates L.P.
6.71%
BlackRock Institutional Trust Company, N.A.
5.57%
State Street Investment Management (US)
4.45%
GIC Private Limited
3.86%
기타
67.87%
주주 유형
주주
비율
Investment Advisor
47.72%
Investment Advisor/Hedge Fund
36.41%
Sovereign Wealth Fund
4.96%
Pension Fund
4.15%
Hedge Fund
3.24%
Research Firm
2.37%
Bank and Trust
2.01%
Individual Investor
0.92%
Family Office
0.15%
기관 주식 보유
마지막 업데이트: Thu, Jan 1
마지막 업데이트: Thu, Jan 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
2132
171.19M
100.94%
-15.17M
2025Q3
2061
175.98M
103.33%
-829.63K
2025Q2
2053
166.70M
98.05%
-9.45M
2025Q1
2083
168.53M
97.38%
-9.36M
2024Q4
2059
171.87M
97.45%
+3.00M
2024Q3
2008
173.01M
95.44%
+863.78K
2024Q2
1977
164.85M
90.43%
-7.68M
2024Q1
1950
165.50M
90.84%
-10.38M
2023Q4
1948
168.90M
93.03%
-6.38M
2023Q3
1925
170.01M
92.82%
-4.41M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
The Vanguard Group, Inc.
19.41M
11.4%
-186.59K
-0.95%
Sep 30, 2025
Harris Associates L.P.
11.39M
6.69%
-365.92K
-3.11%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
9.44M
5.54%
+67.42K
+0.72%
Sep 30, 2025
State Street Investment Management (US)
7.55M
4.43%
-75.92K
-1.00%
Sep 30, 2025
GIC Private Limited
6.54M
3.84%
-2.59M
-28.36%
Mar 31, 2025
Geode Capital Management, L.L.C.
4.35M
2.55%
+132.36K
+3.14%
Sep 30, 2025
CPP Investments
4.12M
2.42%
-52.91K
-1.27%
Sep 30, 2025
AllianceBernstein L.P.
3.60M
2.11%
+41.64K
+1.17%
Sep 30, 2025
Boston Partners
3.56M
2.09%
+1.58M
+80.09%
Sep 30, 2025
Artisan Partners Limited Partnership
3.43M
2.02%
+161.09K
+4.92%
Sep 30, 2025
더 보기
관련 ETF
마지막 업데이트: Tue, Dec 2
마지막 업데이트: Tue, Dec 2
이름
비율
First Trust Nasdaq Lux Digi Health Solutions ETF
9.1%
Langar Global HealthTech ETF
7.83%
Global X HealthTech ETF
5.5%
VanEck Biotech ETF
4.98%
iShares Biotechnology ETF
3.23%
iShares Health Innovation Active ETF
3.05%
Adaptive Core ETF
3.04%
Invesco Bloomberg Pricing Power ETF
2.24%
Running Oak Efficient Growth ETF
2.16%
Invesco Zacks Mid-Cap ETF
2.08%
더 보기
First Trust Nasdaq Lux Digi Health Solutions ETF
비율9.1%
Langar Global HealthTech ETF
비율7.83%
Global X HealthTech ETF
비율5.5%
VanEck Biotech ETF
비율4.98%
iShares Biotechnology ETF
비율3.23%
iShares Health Innovation Active ETF
비율3.05%
Adaptive Core ETF
비율3.04%
Invesco Bloomberg Pricing Power ETF
비율2.24%
Running Oak Efficient Growth ETF
비율2.16%
Invesco Zacks Mid-Cap ETF
비율2.08%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
배당락일
유형
비율
데이터 없음
날짜
배당락일
유형
비율
데이터 없음
